1,046 results on '"Palmqvist, Richard"'
Search Results
2. Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients
3. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer – possible implications for immunotherapy
4. Untargeted plasma metabolomics and risk of colorectal cancer—an analysis nested within a large-scale prospective cohort
5. Association of pre-diagnostic physical exercise and peri-diagnostic body composition with mortality in non-metastatic colorectal cancer
6. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer
7. Implementing precision medicine in a regionally organized healthcare system in Sweden
8. Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
9. Sporadic deficient mismatch repair in colorectal cancer increases the risk for non‐colorectal malignancy: A European multicenter cohort study
10. Inflammation and gut barrier function-related genes and colorectal cancer risk in western European populations
11. Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
12. Inflammation and gut barrier function-related genes and colorectal cancer risk in western European populations
13. Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy : a European multicenter cohort study
14. A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
15. A Prospective Study of the Immune System Activation Biomarker Neopterin and Colorectal Cancer Risk
16. Deficient mismatch repair as a prognostic marker in stage II colon cancer patients
17. Smokeless tobacco (snus) use and colorectal cancer incidence and survival : Results from nine pooled cohorts
18. Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis
19. Nonlinear Relationship of Insulin-like Growth Factor (IGF)-I and IGF-I/IGF-Binding Protein-3 Ratio with Indices of Adiposity and Plasma Insulin Concentrations (Sweden)
20. Rectal cancer: a methodological approach to matching PET/MRI to histopathology
21. Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer
22. A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
23. Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy
24. Abstract LB142: Metabolically defined body size phenotypes in relation to subsequent colorectal cancer risk
25. Abstract 733: Relationship between pre-diagnostic biomarkers and sarcopenia in colorectal cancer patients
26. Data from Metabolic Syndrome and Risks of Colon and Rectal Cancer: The European Prospective Investigation into Cancer and Nutrition Study
27. Supplementary Table 1 from Metabolic Syndrome and Risks of Colon and Rectal Cancer: The European Prospective Investigation into Cancer and Nutrition Study
28. Supplementary Tables 1-2 from Prediagnostic 25-Hydroxyvitamin D, VDR and CASR Polymorphisms, and Survival in Patients with Colorectal Cancer in Western European Populations
29. Data Supplement from Low Folate Levels Are Associated with Reduced Risk of Colorectal Cancer in a Population with Low Folate Status
30. Supplementary Data from The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status
31. Data from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
32. Data from Insulin-like Growth Factor-II Methylation Status in Lymphocyte DNA and Colon Cancer Risk in the Northern Sweden Health and Disease Cohort
33. Supplementary Materials from Insulin-like Growth Factor-II Methylation Status in Lymphocyte DNA and Colon Cancer Risk in the Northern Sweden Health and Disease Cohort
34. Supplementary Figure 1 from Insulin-like Growth Factor-II Methylation Status in Lymphocyte DNA and Colon Cancer Risk in the Northern Sweden Health and Disease Cohort
35. Supplementary Table 3 from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
36. Supplementary Figure 2 from Insulin-like Growth Factor-II Methylation Status in Lymphocyte DNA and Colon Cancer Risk in the Northern Sweden Health and Disease Cohort
37. Supplementary Figure 3 from Insulin-like Growth Factor-II Methylation Status in Lymphocyte DNA and Colon Cancer Risk in the Northern Sweden Health and Disease Cohort
38. Supplementary Table 1 from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
39. Supplementary Table 5 from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
40. An epigenome-wide analysis of sex hormone levels and DNA methylation in male blood samples
41. Supplementary Table 4 from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
42. Supplementary Table 2 from Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort
43. Plasma concentrations of gut hormones acyl ghrelin and peptide YY and subsequent risk of colorectal cancer and molecular tumor subtypes
44. An epigenome-wide analysis of sex hormone levels and DNA methylation in male blood samples
45. Components of One-carbon Metabolism Other than Folate and Colorectal Cancer Risk
46. PET/MRI and PET/CT hybrid imaging of rectal cancer – description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study
47. Clinicopathological and biological differences in patients with early-onset colon cancer over time - a retrospective cohort study.
48. Tumour Colonisation of Parvimonas micra Is Associated with Decreased Survival in Colorectal Cancer Patients
49. Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent Risk of Colorectal Cancer and Molecular Tumor Subtypes
50. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.